Madam Speaker, I agree with my colleague on one thing, and that is about the member for Winnipeg North. I do not agree with him, however, on the reasons why the Bloc Québécois opposes the pharmacare plan. We oppose it because it directly interferes in Quebec's jurisdictions.
I would like to point something out to my colleague, because he spoke at length about rare diseases. In the early 2000s, there were seven major pharmaceutical companies doing research in Canada, six of which were based in Quebec. There was a program at the time that gave them access to tax credits. If I remember correctly, it was called technology partnerships Canada.
The government that shut it down was Stephen Harper's in 2007. In hindsight, does my colleague think that was a bad idea?